17-76531631-A-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_134268.5(CYGB):c.204T>A(p.Asp68Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000639 in 1,612,468 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_134268.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYGB | NM_134268.5 | c.204T>A | p.Asp68Glu | missense_variant | 2/4 | ENST00000293230.10 | NP_599030.1 | |
CYGB | XM_005257005.4 | c.204T>A | p.Asp68Glu | missense_variant | 2/4 | XP_005257062.1 | ||
CYGB | XM_017024116.2 | c.9T>A | p.Asp3Glu | missense_variant | 2/4 | XP_016879605.1 | ||
PRCD | NR_033357.2 | n.248+3798A>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYGB | ENST00000293230.10 | c.204T>A | p.Asp68Glu | missense_variant | 2/4 | 1 | NM_134268.5 | ENSP00000293230 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000658 AC: 10AN: 152086Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000519 AC: 13AN: 250520Hom.: 0 AF XY: 0.0000738 AC XY: 10AN XY: 135448
GnomAD4 exome AF: 0.0000637 AC: 93AN: 1460382Hom.: 0 Cov.: 32 AF XY: 0.0000675 AC XY: 49AN XY: 726132
GnomAD4 genome AF: 0.0000658 AC: 10AN: 152086Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74292
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 14, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at